Guomin Xie

703 total citations
26 papers, 480 citations indexed

About

Guomin Xie is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guomin Xie has authored 26 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guomin Xie's work include Liver physiology and pathology (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Guomin Xie is often cited by papers focused on Liver physiology and pathology (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Guomin Xie collaborates with scholars based in China, United States and Saudi Arabia. Guomin Xie's co-authors include Aijuan Qu, Frank J. Gonzalez, Yanting Song, Baoqi Yu, Hua Wang, Tomoki Yagai, Jie Du, Yujing Liu, Dan Qi and Ming Wei and has published in prestigious journals such as Hepatology, The FASEB Journal and Pharmacology & Therapeutics.

In The Last Decade

Guomin Xie

23 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guomin Xie China 13 223 90 79 69 68 26 480
Fan Xiao China 14 211 0.9× 109 1.2× 69 0.9× 62 0.9× 28 0.4× 40 452
Liang Xie United States 13 248 1.1× 84 0.9× 106 1.3× 99 1.4× 108 1.6× 20 568
Ramasamy Selvarani United States 6 224 1.0× 125 1.4× 48 0.6× 66 1.0× 116 1.7× 10 462
Daniela Lambertz Germany 9 169 0.8× 133 1.5× 51 0.6× 44 0.6× 56 0.8× 14 383
Fiona O’Mahony Ireland 14 303 1.4× 74 0.8× 68 0.9× 38 0.6× 69 1.0× 17 728
Jiaxin Li China 13 320 1.4× 165 1.8× 161 2.0× 44 0.6× 40 0.6× 48 593
Masaaki Iwabayashi Japan 11 179 0.8× 86 1.0× 44 0.6× 41 0.6× 53 0.8× 24 442
Shu Zhuo China 15 326 1.5× 138 1.5× 123 1.6× 62 0.9× 91 1.3× 22 674

Countries citing papers authored by Guomin Xie

Since Specialization
Citations

This map shows the geographic impact of Guomin Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guomin Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guomin Xie more than expected).

Fields of papers citing papers by Guomin Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guomin Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guomin Xie. The network helps show where Guomin Xie may publish in the future.

Co-authorship network of co-authors of Guomin Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Guomin Xie. A scholar is included among the top collaborators of Guomin Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guomin Xie. Guomin Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yeping, Cheng Zheng, Junxiao Hu, et al.. (2025). Target inhibition of SPAK in choroid plexus attenuates T cell infiltration and demyelination in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 22(1). 80–80.
2.
Zhao, Wen, et al.. (2025). Potential Applications of Natural Components of Traditional Chinese Medicine Delivery via Nanoparticle Drug Delivery Systems in the Treatment of Alzheimer’s Disease. International Journal of Nanomedicine. Volume 20. 7781–7810. 3 indexed citations
3.
Xie, Guomin, et al.. (2025). Clinical features of recurrent MOG antibody-associated cortical encephalitis in adults. Neurological Sciences. 46(5). 1987–1993.
4.
Zhou, Huan, Liang Wang, Hongfang Chen, et al.. (2025). The Efficacy of Intensive Statin Therapy in Acute Ischemic Stroke Following Intravenous Thrombolysis: The CASE II Study. CNS Neuroscience & Therapeutics. 31(1). e70186–e70186.
6.
Fan, Shicheng, Yue Gao, Guomin Xie, et al.. (2024). Fenofibrate-promoted hepatomegaly and liver regeneration are PPARα-dependent and partially related to the YAP pathway. Acta Pharmaceutica Sinica B. 14(7). 2992–3008. 5 indexed citations
7.
Zheng, Cheng, Kaikai Hu, Xiao Dong Chen, et al.. (2024). The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson’s disease. Frontiers in Pharmacology. 15. 1468850–1468850. 2 indexed citations
9.
Hao, Yanan, et al.. (2023). Prediction factors and clinical significance of different types of hemorrhagic transformation after intravenous thrombolysis. European journal of medical research. 28(1). 509–509. 6 indexed citations
10.
Yu, Baoqi, et al.. (2022). The role of hypoxia-inducible factors in cardiovascular diseases. Pharmacology & Therapeutics. 238. 108186–108186. 56 indexed citations
11.
Xie, Guomin, Yanting Song, Na Li, et al.. (2021). Myeloid peroxisome proliferator-activated receptor α deficiency accelerates liver regeneration via IL-6/STAT3 pathway after 2/3 partial hepatectomy in mice. HepatoBiliary Surgery and Nutrition. 11(2). 199–211. 13 indexed citations
12.
Li, Na, Guomin Xie, Biao Zhou, et al.. (2021). Serum Adropin as a Potential Biomarker for Predicting the Development of Type 2 Diabetes Mellitus in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease. Frontiers in Physiology. 12. 696163–696163. 20 indexed citations
14.
Wei, Ming, Xia Wang, Yanting Song, et al.. (2021). Inhibition of Peptidyl Arginine Deiminase 4-Dependent Neutrophil Extracellular Trap Formation Reduces Angiotensin II-Induced Abdominal Aortic Aneurysm Rupture in Mice. Frontiers in Cardiovascular Medicine. 8. 676612–676612. 29 indexed citations
15.
Wang, Haifeng, et al.. (2021). Increased systemic immune-inflammation index can predict respiratory failure in patients with Guillain-Barré syndrome. Neurological Sciences. 43(2). 1223–1231. 13 indexed citations
16.
Fan, Shicheng, Yue Gao, Aijuan Qu, et al.. (2021). YAP‐TEAD mediates PPAR α–induced hepatomegaly and liver regeneration in mice. Hepatology. 75(1). 74–88. 77 indexed citations
17.
Xiao, Xi, Xinxin Xu, Fangjuan Li, Guomin Xie, & Tao Zhang. (2019). Anti-inflammatory treatment with β-asarone improves impairments in social interaction and cognition in MK-801 treated mice. Brain Research Bulletin. 150. 150–159. 34 indexed citations
18.
Xie, Cen, Shogo Takahashi, Chad Brocker, et al.. (2019). Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1864(10). 1396–1411. 40 indexed citations
19.
Qi, Dan, Ming Wei, Yanting Song, et al.. (2019). Hypoxia inducible factor 1α in vascular smooth muscle cells promotes angiotensin II-induced vascular remodeling via activation of CCL7-mediated macrophage recruitment. Cell Death and Disease. 10(8). 544–544. 65 indexed citations
20.
Xie, Guomin, et al.. (2018). Enhanced Regeneration and Hepatoprotective Effects of Interleukin 22 Fusion Protein on a Predamaged Liver Undergoing Partial Hepatectomy. Journal of Immunology Research. 2018. 1–12. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026